- Report
- February 2026
- 250 Pages
Global
From €4034EUR$4,490USD£3,455GBP
- Report
- October 2025
- 160 Pages
Global
From €2839EUR$3,160USD£2,432GBP
€3548EUR$3,950USD£3,039GBP
- Report
- March 2026
- 130 Pages
Global
From €4357EUR$4,850USD£3,732GBP
- Report
- April 2026
- 200 Pages
Global
From €2686EUR$2,990USD£2,301GBP
- Report
- June 2026
- 181 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- June 2026
- 193 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- February 2026
- 250 Pages
Global
From €4034EUR$4,490USD£3,455GBP
- Report
- February 2026
- 250 Pages
Global
From €4034EUR$4,490USD£3,455GBP
- Report
- August 2026
- 172 Pages
Global
From €5255EUR$5,850USD£4,501GBP
- Report
- June 2026
- 110 Pages
Global
From €4267EUR$4,750USD£3,655GBP
- Report
- May 2026
- 160 Pages
Global
From €3548EUR$3,950USD£3,039GBP
- Report
- March 2026
- 195 Pages
Global
From €4487EUR$4,995USD£3,844GBP
- Report
- April 2026
- 192 Pages
United States
From €4357EUR$4,850USD£3,732GBP
- Report
- August 2024
- 120 Pages
India
From €2426EUR$2,700USD£2,078GBP
- Report
- July 2025
- 200 Pages
Europe
From €2237EUR$2,490USD£1,916GBP
- Report
- December 2022
- 223 Pages
Global
From €2358EUR$2,625USD£2,020GBP
€4716EUR$5,250USD£4,040GBP
- Report
- December 2023
- 152 Pages
Global
From €5345EUR$5,950USD£4,578GBP
- Report
- August 2025
- 180 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- December 2024
- 82 Pages
India
From €3144EUR$3,500USD£2,693GBP
- Report
- July 2024
- 82 Pages
India
From €3144EUR$3,500USD£2,693GBP

The Prostate Specific Antigen (PSA) Test is a diagnostic tool used to detect the presence of prostate cancer in men. It measures the amount of PSA, a protein produced by the prostate gland, in the blood. Elevated levels of PSA may indicate the presence of prostate cancer, although other conditions such as benign prostatic hyperplasia can also cause elevated PSA levels. The PSA Test is typically used in conjunction with other tests such as digital rectal examination and biopsy to confirm a diagnosis of prostate cancer.
The PSA Test market is a subset of the larger Diagnostics market, which includes a wide range of tests used to diagnose and monitor diseases. The Diagnostics market is highly competitive, with a variety of companies offering a range of products and services.
Some companies in the Prostate Specific Antigen Test market include Abbott Laboratories, Beckman Coulter, Siemens Healthineers, Roche Diagnostics, and Quest Diagnostics. Show Less Read more